|
Sep 26
|
Crinetics Submits New Drug Application for Paltusotine for the Treatment of Acromegaly
|
|
Sep 10
|
Crinetics Pharmaceuticals Announces September 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
|
|
Sep 5
|
Crinetics Pharmaceuticals, Inc. (CRNX): Among the Best Mid-Cap Healthcare Stocks To Buy Now
|
|
Jun 26
|
Insider Sale: Chief Scientific Officer Stephen Betz Sells Shares of Crinetics Pharmaceuticals ...
|
|
Jun 18
|
EY Announces Scott Struthers, Ph.D., CEO and Founder of Crinetics Pharmaceuticals, as an Entrepreneur Of The Year® 2024 Pacific Southwest Award Winner
|
|
May 13
|
Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Q1 2024 Earnings Call Transcript
|
|
May 11
|
Investors in Crinetics Pharmaceuticals (NASDAQ:CRNX) have seen solid returns of 196% over the past three years
|
|
May 10
|
Crinetics Pharmaceuticals Announces May 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
|
|
May 10
|
Crinetics Pharmaceuticals Inc (CRNX) Reports Q1 2024 Financial Results
|
|
May 9
|
Crinetics Pharmaceuticals, Inc. (CRNX) Reports Q1 Loss, Misses Revenue Estimates
|
|
May 9
|
Crinetics Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update
|
|
May 8
|
Crinetics Pharmaceuticals to Present Advancements from Atumelnant (CRN04894) and Paltusotine Development Programs at ENDO 2024
|
|
May 2
|
Crinetics Pharmaceuticals to Report First Quarter 2024 Financial Results on May 9, 2024
|
|
Apr 11
|
Crinetics Pharmaceuticals Announces April 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
|
|
Mar 26
|
Insider Sell: COO Jeff Knight Sells 32,359 Shares of Crinetics Pharmaceuticals Inc (CRNX)
|
|
Mar 22
|
Insider Sell: Chief Medical and Development Officer Dana Pizzuti Sells 15,089 Shares of ...
|
|
Mar 22
|
Director Matthew Fust Sells 60,000 Shares of Crinetics Pharmaceuticals Inc (CRNX)
|
|
Mar 21
|
Biotech Stock Roundup: GERN, CRNX Gain on Updates, BMY's CAR T Cell Therapy News & More
|
|
Mar 21
|
Crinetics Pharmaceuticals Inc CFO Marc Wilson Sells 6,942 Shares
|
|
Mar 20
|
Crinetics Pharmaceuticals (CRNX) Stock Jumps 19.1%: Will It Continue to Soar?
|